Tobacco carcinogens and the methionine metabolism in human bladder cancer

Publication date: Available online 4 June 2019Source: Mutation Research/Reviews in Mutation ResearchAuthor(s): A. Wojtczyk-Miaskowska, B SchlichtholzAbstractCigarette smoking is a strong risk factor for bladder cancer. It has been shown that the duration of smoking is associated with a poor prognosis and a higher risk of recurrence. This is due to tobacco carcinogens forming adducts with DNA and proteins that participate in the DNA repair mechanisms. Additionally, polymorphisms of genes responsible for methyl group transfer in the methionine cycle and dosages of vitamins (from diet and supplements) can cause an increased risk of bladder cancer. Upregulated DNA methyltransferase 1 expression and activity results in a high level of methylated products of metabolism, as well as hypermethylation of tumor suppressor genes. The development of a market that provides new inhibitors of DNA methyltransferase or alternatives for current smokers is essential not only for patients but also for people who are under the danger of secondhand smoking and can experience its long-term exposure consequences.
Source: Mutation Research Reviews in Mutation Research - Category: Genetics & Stem Cells Source Type: research